EUVIMEDEUVIMED entdecken
Crossref

Role of the gel spacer in safely delivering whole pelvic radiation therapy without central shielding in computed tomography-based image-guided adaptive brachytherapy for uterine cervical cancer patients

Ayaka Nagao, Naoya Murakami, Madoka Sakuramachi, Tairo Kashihara, Kana Takahashi, Tomoya Kaneda, Koji Inaba, Kae Okuma, Hiroyuki Okamoto, Yuko Nakayama, Kan Yonemori, Hiroshi Igaki

Brachytherapy · 2024

DOI: 10.1016/j.brachy.2024.05.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brachytherapy, 2024. Verfasst von Ayaka Nagao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan; Cancer Medicine, Cooperative Graduate School, The Jikei University G…. Hauptthemen laut MEDLINE: Brachytherapy, Uterine Cervical Neoplasms, Gels, Radiotherapy, Image-Guided. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Cancer Center Japan, AMED, National Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: To protect the rectum and bladder from high dose exposure, the Japanese guidelines for managing uterine cervical carcinoma recommend pelvic irradiation with central shielding (CS). Conversely, the European Society for Radiotherapy and Oncology (ESTRO) and the American Brachytherapy Society (ABS) guidelines recommend delivering ≥85 Gy to high-risk clinical target volume D90 (CTVHR D90%). In this study, we investigated whether a gel spacer can enable the safe delivery of the ESTRO/ABS-recommended doses to the target while observing dose constraints for the OARs without using CS in external beam radiation therapy (EBRT). MATERIALS AND METHODS: Twenty patients who received definitive radiation therapy without CS and were treated by brachytherapy with a gel spacer between 2017 and 2022 were retrospectively reviewed. The cumulative doses of EBRT and brachytherapy treatment outcomes and incidence of adverse events were also examined. RESULTS: The median cumulative CTVHR D90%, rectum D2cm3, and bladder D2cm3 were 86.6 Gy, 62.9 Gy, and 72.0 Gy, respectively. The 2-year local control rate was 95%. There were no CTCAE ≥Grade 3 late gastrointestinal or genitourinary adverse events. CONCLUSIONS: The use of gel spacer can enable ESTRO/ABS-recommended dose constraints even without using CS in EBRT, with favorable outcomes and low adverse event rates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrachytherapyUterine Cervical NeoplasmsGelsRadiotherapy, Image-GuidedRadiotherapy DosageHumansFemaleMiddle AgedRetrospective StudiesAgedAdultTomography, X-Ray ComputedOrgans at RiskRadiation ProtectionUrinary BladderRectumAged, 80 and overRadiation InjuriesPelvis

Stichwörter der Autor:innen

CSCentral shieldGel spacerIC/ISImage-guided adaptive brachytherapyUterine cervical cancer

Substanzen

Gels

Autor:innen und Institutionen

  • Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan; Cancer Medicine, Cooperative Graduate School, The Jikei University Graduate School of Medicine, Tokyo, Japan.
  • Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan; Department of Radiation Oncology, Juntendo University Graduate School of Medicine, Tokyo, Japan. Electronic address: n.murakami.zi@juntend…
  • Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Radiation Safety and Quality Assurance Division, National Cancer Center Hospital, Tokyo, Japan.
  • Cancer Medicine, Cooperative Graduate School, The Jikei University Graduate School of Medicine, Tokyo, Japan; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.

Förderung

  • National Cancer Center Japan
  • AMED
  • National Cancer Center

Zitieren

APA

Nagao, A., Murakami, N., Sakuramachi, M., Kashihara, T., Takahashi, K., Kaneda, T., Inaba, K., Okuma, K., Okamoto, H., Nakayama, Y., Yonemori, K., & Igaki, H. (2024). Role of the gel spacer in safely delivering whole pelvic radiation therapy without central shielding in computed tomography-based image-guided adaptive brachytherapy for uterine cervical cancer patients. Brachytherapy. https://doi.org/10.1016/j.brachy.2024.05.007

Vancouver

Nagao A, Murakami N, Sakuramachi M, Kashihara T, Takahashi K, Kaneda T, et al. Role of the gel spacer in safely delivering whole pelvic radiation therapy without central shielding in computed tomography-based image-guided adaptive brachytherapy for uterine cervical cancer patients. Brachytherapy. 2024. doi:10.1016/j.brachy.2024.05.007

BibTeX
@article{Nagao2024,
  author = {Nagao, Ayaka and Murakami, Naoya and Sakuramachi, Madoka and Kashihara, Tairo and Takahashi, Kana and Kaneda, Tomoya and Inaba, Koji and Okuma, Kae and Okamoto, Hiroyuki and Nakayama, Yuko and Yonemori, Kan and Igaki, Hiroshi},
  title = {Role of the gel spacer in safely delivering whole pelvic radiation therapy without central shielding in computed tomography-based image-guided adaptive brachytherapy for uterine cervical cancer patients},
  journal = {Brachytherapy},
  year = {2024},
  doi = {10.1016/j.brachy.2024.05.007}
}
Kostenlos starten →